BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2156316)

  • 1. Role of protooncogenes and transforming growth factors in normal and neoplastic liver growth.
    Fausto N; Mead JE
    Prog Liver Dis; 1990; 9():57-71. PubMed ID: 2156316
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of liver growth: protooncogenes and transforming growth factors.
    Fausto N; Mead JE
    Lab Invest; 1989 Jan; 60(1):4-13. PubMed ID: 2642989
    [No Abstract]   [Full Text] [Related]  

  • 3. [Control of growth and expression of protooncogenes in regenerating liver].
    Zou Y; Gong DZ; Cui XY; Mei MH
    Sheng Li Ke Xue Jin Zhan; 1996 Jan; 27(1):7-12. PubMed ID: 8731976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of oncogene-coded growth factors in the neoplastic process.
    Robbins KC; King CR; Giese NA; Leal F; Igarashi H; Aaronson SA
    Gene Amplif Anal; 1986; 4():161-76. PubMed ID: 2851529
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic regeneration: current concepts and clinical implications.
    Hoffman AL; Rosen HR; Ljubimova JU; Sher L; Podesta LG; Demetriou AA; Makowka L
    Semin Liver Dis; 1994 May; 14(2):190-210. PubMed ID: 8047902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Growth control of mature hepatocytes by platelet-derived growth regulators].
    Nakamura T
    Tanpakushitsu Kakusan Koso; 1989 Jul; 34(9):1049-60. PubMed ID: 2678276
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression.
    Shiota G; Wang TC; Nakamura T; Schmidt EV
    Hepatology; 1994 Apr; 19(4):962-72. PubMed ID: 8138271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protooncogenes and growth factors associated with normal and abnormal liver growth.
    Fausto N
    Dig Dis Sci; 1991 May; 36(5):653-8. PubMed ID: 2022167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transforming growth factors and their role in chronic liver diseases].
    Piotrowska E; Piotrowski J; Grzeszczak W
    Wiad Lek; 1993 May; 46(9-10):378-81. PubMed ID: 8236997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms by which EGF receptor and TGF alpha contribute to malignant transformation.
    Di Marco E; Pierce JH; Aaronson SA; Di Fiore PP
    Nat Immun Cell Growth Regul; 1990; 9(3):209-21. PubMed ID: 2196461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factors in the prostate.
    Wilson EM; Smith EP
    Prog Clin Biol Res; 1987; 239():205-33. PubMed ID: 3309956
    [No Abstract]   [Full Text] [Related]  

  • 12. [A protein associated with growth, hepatic regeneration and tumoral development].
    Dufour D; Brassard A; Tremblay A; Lemieux S
    Pathol Biol; 1967; 15(15):757-61. PubMed ID: 4967410
    [No Abstract]   [Full Text] [Related]  

  • 13. Transforming growth factor beta and liver regeneration: the stage may be set, but what's the script?
    Davis BH; Chen A
    Hepatology; 1996 Jun; 23(6):1703-5. PubMed ID: 8675198
    [No Abstract]   [Full Text] [Related]  

  • 14. Transforming growth factors in the regulation of malignant cell growth and invasion.
    Keski-Oja J; Postlethwaite AE; Moses HL
    Cancer Invest; 1988; 6(6):705-24. PubMed ID: 3072995
    [No Abstract]   [Full Text] [Related]  

  • 15. Prometheus' challenge: molecular, cellular and systemic aspects of liver regeneration.
    Pahlavan PS; Feldmann RE; Zavos C; Kountouras J
    J Surg Res; 2006 Aug; 134(2):238-51. PubMed ID: 16458925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lca as an onco-fetal gene: its expression in human fetal liver.
    Shiozawa M; Ochiya T; Hatada I; Imamura T; Okudaira Y; Hiraoka H; Matsubara K
    Oncogene; 1988 May; 2(5):523-6. PubMed ID: 2836781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of growth regulation in liver regeneration and hepatic carcinogenesis.
    Fausto N; Webber EM
    Prog Liver Dis; 1993; 11():115-37. PubMed ID: 8272507
    [No Abstract]   [Full Text] [Related]  

  • 18. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factors and cancer.
    Goustin AS; Leof EB; Shipley GD; Moses HL
    Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomethylation of c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver.
    Kaneko Y; Shibuya M; Nakayama T; Hayashida N; Toda G; Endo Y; Oka H; Oda T
    Jpn J Cancer Res; 1985 Dec; 76(12):1136-40. PubMed ID: 3005205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.